Photoswitchable glycoligands targeting Pseudomonas aeruginosa LecA.
Yu FanAhmed El RhazStéphane MaisonneuveEmilie GillonMaha FatthallaFranck Le BideauGuillaume LaurentSamir MessaoudiAnne ImbertyJuan XiePublished in: Beilstein journal of organic chemistry (2024)
Biofilm formation is one of main causes of bacterial antimicrobial resistance infections. It is known that the soluble lectins LecA and LecB, produced by Pseudomonas aeruginosa , play a key role in biofilm formation and lung infection. Bacterial lectins are therefore attractive targets for the development of new antibiotic-sparing anti-infective drugs. Building synthetic glycoconjugates for the inhibition and modulation of bacterial lectins have shown promising results. Light-sensitive lectin ligands could allow the modulation of lectins activity with precise spatiotemporal control. Despite the potential of photoswitchable tools, few photochromic lectin ligands have been developed. We have designed and synthesized several O - and S -galactosyl azobenzenes as photoswitchable ligands of LecA and evaluated their binding affinity with isothermal titration calorimetry. We show that the synthesized monovalent glycoligands possess excellent photophysical properties and strong affinity for targeted LecA with K d values in the micromolar range. Analysis of the thermodynamic contribution indicates that the Z -azobenzene isomers have a systematically stronger favorable enthalpy contribution than the corresponding E -isomers, but due to stronger unfavorable entropy, they are in general of lower affinity. The validation of this proof-of-concept and the dissection of thermodynamics of binding will help for the further development of lectin ligands that can be controlled by light.
Keyphrases
- biofilm formation
- pseudomonas aeruginosa
- antimicrobial resistance
- cystic fibrosis
- staphylococcus aureus
- candida albicans
- escherichia coli
- acinetobacter baumannii
- cancer therapy
- capillary electrophoresis
- low density lipoprotein
- mass spectrometry
- multidrug resistant
- robot assisted
- human health
- oxide nanoparticles
- minimally invasive
- human serum albumin